Education
About Us
Working with TipRanks
Follow Us
Zeeshan Saeed Insider Profile
4 Followers
Zeeshan Saeed, Co-Chairman & Chief Executive Officer at Quantum Biopharma, holds 125.19K shares in Quantum Biopharma (Ticker: QNTM). Most recently, Zeeshan Saeed Bought 300 shares of Quantum Biopharma on Aug 08, 2025 for an estimated value of $7.95K.
Zeeshan Saeed Quantum Biopharma (QNTM)Co-Chairman & Chief Executive Officer
Quantum Biopharma (QNTM)
Co-Chairman & Chief Executive Officer
Ranked #4,946 out of 102,971 Corporate Insiders
Profitable Transactions
22 out of 37 Profitable Transactions
Average Return
+13.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Co-Chairman & Chief Executive Officer
Roles that Zeeshan Saeed holds in companies
Most Profitable Insider Trade
The most profitable trade made by Zeeshan Saeed
Zeeshan Saeed's Trading History
List of latest transactions for each holding click on a transaction to see Zeeshan Saeed's performance on stock
You May Also Like
Zeeshan Saeed insider profile FAQ
What is the percentage of profitable transactions made by Zeeshan Saeed?
The percentage of profitable transactions made by Zeeshan Saeed is 59%.
What is the average return per transaction made by Zeeshan Saeed?
The average return per transaction made by Zeeshan Saeed is 13.70%.
What stocks does Zeeshan Saeed hold?
Zeeshan Saeed holds: QNTM stocks.
What was Zeeshan Saeed’s latest transaction?
Zeeshan Saeed latest transaction was an Informative Buy of $7.95K.
What was Zeeshan Saeed's most profitable transaction?
Zeeshan Saeed’s most profitable transaction was an Informative Buy of QNTM stock on April 12, 2022. The return on the trade was 108.80%.
What is Zeeshan Saeed's role in Quantum Biopharma?
Zeeshan Saeed's role in Quantum Biopharma is Co-Chairman & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.